Dizal Pharma

Pharma

Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia

Takeda aims to save $1.3 billion in a restructuring. Generic semaglutide launches started in India. Gilead offered to buy a Chinese "NewCo." And more.

Angus Liu Mar 27, 2026 8:38am

Dizal's Zegfrovy adds more pressure to J&J's Rybrevant

Mar 23, 2026 10:25am

Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia

Jul 10, 2025 5:20pm

FDA signs off on AZ spinout Dizal's lung cancer drug Zegfrovy

Jul 7, 2025 11:28am

Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia

Jun 28, 2024 8:40am

Despite J&J's full nod, FDA endorses Dizal's accelerated plan

Jun 26, 2024 11:08am